Company Filing History:
Years Active: 1996-2001
Title: The Innovations of Robert B Hermann
Introduction
Robert B Hermann is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical applications. With a total of three patents to his name, Hermann's work has the potential to impact the treatment of serious health conditions.
Latest Patents
Hermann's latest patents include innovative compounds such as 1H-indole-3-acetamide sPLA2 inhibitors. This class of novel 1H-indole-3-acetamides is designed to inhibit sPLA2-mediated release of fatty acids, which can be crucial in treating conditions like septic shock. Another patent focuses on a similar class of compounds represented by a specific formula, aimed at the same therapeutic applications.
Career Highlights
Robert B Hermann is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation in healthcare. His work at Eli Lilly has allowed him to explore and develop groundbreaking solutions that address critical medical needs.
Collaborations
Hermann has collaborated with esteemed colleagues such as Nicholas J Bach and Robert D Dillard. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Robert B Hermann's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to significantly improve treatment options for patients facing serious health challenges.